SEC Form 4 research
| Issuer | Celsus Therapeutics Plc. |
|---|---|
| Tickers | CLTX, AKTX |
| Reporting owners | 34 |
| Officers and directors | 2 |
| Last public filing | 2026-10-16 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-05 | Prudo-Chlebosz Raymond | A | 3,240 | $7.9 | Not reported |
| 2026-10-16 | 2026-08-18 | Prudo-Chlebosz Raymond | A | 15,000 | $0 | Not reported |
| 2026-10-16 | 2026-08-18 | Prudo-Chlebosz Raymond | A | 9,072 | $7.9 | Not reported |
| 2026-10-16 | 2026-08-18 | Prudo-Chlebosz Raymond | A | 30,000 | $0 | Not reported |
| 2026-10-16 | 2026-10-05 | Huh Hoyoung | A | 6,160 | $7.9 | Not reported |
| 2026-10-16 | 2026-08-18 | Huh Hoyoung | A | 15,000 | $0 | Not reported |
| 2026-10-16 | 2026-08-18 | Huh Hoyoung | A | 17,249 | $7.9 | Not reported |
| 2026-10-16 | 2026-08-18 | Huh Hoyoung | A | 30,000 | $0 | Not reported |
| 2026-10-16 | 2026-10-05 | Patel Sandip I | A | 4,313 | $7.9 | Not reported |
| 2026-10-16 | 2026-08-18 | Patel Sandip I | A | 15,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.